News - Summit Pharmaceuticals

Filter

Current filters:

Summit Pharmaceuticals

Popular Filters

Summit Pharma gets exclusive agency for Neuralstem’s NSI-189 in Japan

08-06-2011

USA-based stem cell development firm Neuralstem (NYSE Amex: CUR) has signed an exclusive agency licensing…

LicensingNeuralstemNeurologicalPharmaceuticalSummit Pharmaceuticals

Back to top